Cobalt inhibits liver haem synthesis in vivo by acting at least two different sites in the biosynthetic pathway: (1) synthesis of 5-aminolaevulinate and (2) conversion of 5-aminolaevulinate into haem. The first effect is largely, if not entirely, due to inhibition of the activity of 5-aminolaevulinate synthase, rather than to inhibition of the formation of the enzyme. The second effect results from diversion of 5-aminolaevulinate into an unidentified liver pool with solubility properties similar to those of cobalt protoporphyrin.
Cobalt inhibits liver haem synthesis in vivo by acting at least two different sites in the biosynthetic pathway: (1) synthesis of 5-aminolaevulinate and (2) conversion of 5-aminolaevulinate into haem. The first effect is largely, if not entirely, due to inhibition of the activity of 5-aminolaevulinate synthase, rather than to inhibition of the formation of the enzyme. The second effect results from diversion of 5-aminolaevulinate into an unidentified liver pool with solubility properties similar to those of cobalt protoporphyrin.
Rats given cobalt show a marked loss of haemoproteins, particularly cytochrome P-450, from their livers (Tephly & Hibbeln, 1971; Yasukochi et al., 1974) . Studies conducted in vivo with labelled precursors of the haem moieties of microsomal cytochromes and catalase have indicated that cobalt interferes with haem metabolism (Tephly et al., 1973; Yasukochi et al., 1974) , both by accelerating haem breakdown (De Matteis & Unseld, 1976; and also by inhibiting haem synthesis (Nakamura et al., 1975; De Matteis & Gibbs, 1976 ).
The present results, which are an extension of a recent study (De Matteis & Gibbs, 1976) , indicate that cobalt inhibits liver haem synthesis at least two different stages in the biosynthetic sequence: (1) formation of 5-aminolaevulinate and (2) conversion of 5-aminolaevulinate into haem. The first effect is probably due to decreased activity of 5-aminolaevulinate synthase (EC 2.3.1.37), rather than to inhibition of the formation of the enzyme, or to limited generation of its substrate, succinyl-CoA (3-carboxypropionyl-CoA), and the second to a diversion of 5-aminolaevulinate into an unidentified liver component(s) which is different from haem and has solubility properties similar to those of cobalt protoporphyrin.
Materials and Methods
Male rats (160-180g) of the Porton strain were first starved overnight, then injected subcutaneously with CoCI2,6H20 (60mg in lOml of 0.85 % NaCI/kg body wt.) and kept starved for the duration of the experiments. Some rats were given 3,5-diethoxycarbonyl-1,4-dihydrocollidine dissolved in arachis oil either by intraperitoneal injection (100mg/kg) or orally (200mg/kg) (2, cCi, 37nmol) intraperitoneally and killing them 15min and 10min to 24h later respectively. Haemin was isolated from the homogenates of livers, after addition of horse erythrocyte lysate, and crystallized (Labbe & Nishida, 1957) ; the liver proteins were isolated as described by Villa-Trevinio et al. (1963) . Their radioactivity and that of the total liver homogenate was determined by liquid-scintillation counting (after combustion in an Intertechnique Oxymat in the case of haemin).
5-Aminolaevulinate synthase was assayed in whole liver homogenates (Abbritti & De Matteis, 1971) or in isolated mitochondria as described by De Matteis (1971) , except that mitochondria were sonicated for lOs (with aDawe Soniprobe type 7530A at 3 A) before incubation and pyridoxal phosphate was present in the assay medium at a final concentration of 0.8 mm. Succinyl-CoA was prepared as described by Simon & Shemin (1953) and determined by the method of Lipmann & Tuttle (1945) . On account of the instability of succinyl-CoA, when measuring formation of 5-aminolaevulinate, succinyl-CoA was added in successive amounts calculated to maintain a constant concentration throughout the 30min incubation: an initial 1 pmol was followed by 0.44umol every 5min.
The disappearance of succinyl-CoA was measured by adding lOjumol to the complete incubation mixture at the beginning of the incubation and measuring the amount remaining after 15 min.
Resudts and Discussion
Inhibition of 5-aminolaevuidnate synthase activity When starved rats were given a single subcutaneous injection ofCoCI2 (256,umol/kg) 
X12 (4) (5) Fig. l(b) for 3,5-diethoxycarbonyl-1,4-dihydrocollidine. They suggest that cobalt inhibits the induced synthesis of the enzyme. An alternative explanation is that cobalt inhibits the enzyme activity, rather than its formation.
In order to distinguish between these two mechnisms cobalt was administered to rats 5h after 3,5-diethoxycaubonyl-1,4-dihydrocollidine, when the activity of 5-aninolaevulinate synthase was already stimulated. The rate of loss of activity was greater after cobalt administration than after cycloheximide, suggesting that cobalt could not act merely by blocking the formation of the enzyme (Fig. Ic) Effect of cobalt on the metabolism of 5-aminolaevulinate in vivo When cobalt-treated rats are injected with radioactive 5-aminolaevulinate the radioactivities recovered either as haemin from the liver (Tephly et al., 1973; Nakamura et al., 1975; De Matteis & Gibbs, 1976) or as bilirubin from bile (De Matteis & Gibbs, 1976) are both markedly decreased. This suggests that cobalt inhibits liver haem synthesis also by acting at some stage in the pathway after the synthesis of 5-aminolaevulinate. Guzelian & Bissell (1976) have concluded, on the other hand, that cobalt does not inhibit liver haem synthesis.
To eui te he nature of the inhibition by cobalt of the uptake of radioactive 5-amnolaevulinate imto crystallizable liver haem, intact rats were injeced with cobalt, and after Ih with labeled 5-aminolaevulinate, and they were killed at different times after the label. At all times the total radioactivityrecovered in the liver was not significantly differt in cobalttreated rats from that in controls, In contrast, the radioactivity isolated as crystaine haemin from the liver homogenate was significantly decreased in cobalt-treated rats (Fig. 2) .
These results indicate that cobalt pretreatment caused accumulation of radioactivity from 5-aminolaevulinate in a form that could not be extracted and crystallized as haemin and also that this non-crystallizable radioactivity was not readily eliminated from the liver. This effect of cobalt cannot arise from an interference with either the extraction or the crystallization of haem, since, when rats were first given radioactive 5-aminolaevulinate and were then treated with cobalt 2h later, after the incorporation of the label into haem was essentially complete, no increase in non-haem radioactivity was found (De Matteis & Unseld, 1976) . Therefore the accumulation of nonhaem radioactivity must represent a change in the liver metabolism of5-aminolaevulinate with diversion ofradioactivity into one or more relatively stable liver pools, different from haem.
The nature of the non-haem compound(s) that are labelled in the liver under the conditions of these experiments is not known. The following preliminary experiment indicates that most of this non-haem radioactivity is not readily extractable by acidified acetone, a behaviour similar to that of authentic cobalt protoporphyrin. When liver homogenates from rats killed 1 h after injection of 5-amino[14C]-laevulinate ( Fig. 2) were repeatedly extracted with acetone/conc. HCI (99: 1, v/v) , the percentage of the total radioactivity remaining in the extracted pellet was 68 % for cobalt-treated livers, but only 26 % for control livers (with the balance of radioactivity being present in the extracts in both cases). When authentic cobalt protoporphyrin or authentic haem was added to liver homogenates, the percentage of the total amount added remaining in the pellet after extraction was 79 and 30 % respectively. If, in fact, cobalt protoporphyrin is formed and accumulates under these conditions, then the possibility should be considered (De Matteis, 1975 ) that this haem-like compound mayberesponsible for the inhibition of5-aminolaevulinate synthase by a mechanism similar to that involved in feedback inhibition of the enzyme by haem.
